{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:17:49Z","timestamp":1792192669673,"version":"4.4.0"},"reference-count":7,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/wnf.0000000000000020","type":"journal-article","created":{"date-parts":[[2014,3,10]],"date-time":"2014-03-10T13:07:11Z","timestamp":1394456831000},"page":"52-54","source":"Crossref","is-referenced-by-count":12,"title":["Generalized Myoclonus and Spasticity Induced by Lamotrigine Toxicity"],"prefix":"10.1097","volume":"37","author":[{"given":"Hussein A.","family":"Algahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Aldarmahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed W.","family":"Al-Rabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed H.","family":"Almalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bryan Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-3-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4088\/JCP.v58n0607b","article-title":"Treatment refractory bipolar disorder treated with lamotrigine.","volume":"58","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R5-3-20210203","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00004714-199706000-00008","article-title":"The anticonvulsant lamotrigine in treatment-resistant manic depressive illness.","volume":"17","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"R34-3-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000026527","article-title":"Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder.","volume":"38","year":"1998","journal-title":"Neuropsychobiology"},{"key":"R37-3-20210203","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1017\/S0012162206000843","article-title":"Aggravation of epilepsy by anti-epileptic drugs.","volume":"48","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"R38-3-20210203","first-page":"545","article-title":"Tetanus: pathophysiology, management and prophylaxis.","volume":"37","year":"1991","journal-title":"Dis Mon"},{"key":"R39-3-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0079-6123(06)61013-3","article-title":"Sodium channel expression and the molecular pathophysiology of pain after SCI.","volume":"161","year":"2007","journal-title":"Prog Brain Res"},{"key":"R40-3-20210203","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1528-1167.2010.02640.x","article-title":"Sodium channel SCN1A and epilepsy: mutations and mechanisms.","volume":"51","year":"2010","journal-title":"Epilepsia"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:09:36Z","timestamp":1620976176000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201403000-00003"}},"subtitle":["A Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000020","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}